[144] Ares Management Corp SEC Filing
Rhea-AI Filing Summary
ARES Management has a holder filing a notice to sell common stock under Rule 144. The filing covers a proposed sale of 590,000 common shares through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $86,983,700. The issuer reports 216,852,343 common shares outstanding and the approximate sale date listed is 11/24/2025 on the NYSE.
The seller acquired these shares as founders shares from the issuer on 05/02/2014. The notice also discloses prior Rule 10b5-1 plan sales by Atticus Enterprises LLC, including a sale of 44,760 common shares on 08/25/2025 for gross proceeds of $7,975,820.21. By signing, the seller represents they are not aware of undisclosed material adverse information about ARES.
Positive
- None.
Negative
- None.
FAQ
What does the ARES Form 144 filing disclose about planned share sales?
The Form 144 notice for ARES (ARES) discloses an intended sale of 590,000 common shares through Morgan Stanley Smith Barney LLC on or about 11/24/2025, to be traded on the NYSE, with an aggregate market value of $86,983,700.
How many ARES shares are outstanding according to this Form 144?
The notice states that 216,852,343 common shares of ARES were outstanding at the time referenced in the filing, providing context for the planned Rule 144 sale.
How and when were the ARES shares in this Form 144 originally acquired?
The shares covered by this Form 144 were acquired as founders shares from the issuer on 05/02/2014, with 590,000 common shares reported as acquired on that date.
What prior ARES share sales are disclosed for the past three months?
The filing reports prior Rule 10b5-1 sales for Atticus Enterprises LLC, including a sale of 44,760 ARES common shares on 08/25/2025 for $7,975,820.21 in gross proceeds.
Which broker is handling the proposed ARES share sale under this Form 144?
The proposed sale of 590,000 ARES common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
What representation does the seller make in the ARES Form 144 filing?
The seller represents that they do not know any material adverse information about the current or prospective operations of ARES that has not been publicly disclosed, and this representation also applies as of the Rule 10b5-1 plan adoption date if such a plan is used.
Is the ARES Form 144 sale related to a trading plan under Rule 10b5-1?
The section on past three months’ sales identifies 10b5-1 sales for Atticus Enterprises LLC, and the signature language describes how representations apply if a written trading plan under Rule 10b5-1 has been adopted.